A bdominal aortic aneurysms (AAAs), characterized by a permanent, localized dilatation (ballooning) of the abdominal aorta that exceeds the normal diameter by >50%, are the most common form of aortic aneurysm. AAA rupture and the associated catastrophic physiological insult carry an overall mortality rate in excess of 80%; ruptured AAAs are the 13th leading cause of death in the United States.
are >65 years old, indicating that age is a major risk factor for AAAs. 2 Although age-related alterations such as enhanced inflammatory responses, vascular stiffening, and oxidative stress make aged arteries more susceptible to vascular diseases, such as atherosclerosis, [5] [6] [7] the reasons why AAAs are often observed in patients with advanced age (>65 years) and how advanced age dramatically accelerates the development and progression of aneurysms in abdominal aortas remain unknown. Furthermore, little is known about the contributions of vascular aging in AAAs and whether an alteration of age-related molecules is required for AAA initiation and progression.
Sir2 (silent information regulator 2) proteins (sirtuins), a conserved nicotinamide adenine dinucleotide-dependent protein deacetylase, play critical roles in improving metabolism and healthspan. [8] [9] [10] SIRT1 (Sirtuin 1), the best characterized mammalian sirtuin, is highly expressed in the vasculature 11 and is an important modulator of cardiovascular functions in health and disease. Several studies from our laboratory and others indicate that SIRT1 protects against stress-induced vascular remodeling`, 12, 13 aortic stiffness and dissection, 14, 15 and atherosclerosis in mice, [16] [17] [18] suggesting a critical role of SIRT1 in vascular diseases. The activation of SIRT1 confers protective effects on atherosclerosis involving vascular endothelial and smooth muscle cell senescence. [18] [19] [20] Despite that advanced age is a known risk factor for AAAs, whether advanced age accelerates AAA formation in mice and the molecular mechanisms that link vascular cell senescence and AAA formation remain elusive. Here, we report that the expression and activity of SIRT1 were significantly decreased in human AAA samples. Age-associated SIRT1 reduction in vascular smooth muscle cells (VSMCs) of abdominal aortas increases their susceptibility to AAAs in mice. The reduction of SIRT1 was shown to increase vascular cell senescence, upregulate the expression of p21, and enhance inflammatory cell recruitment for vascular inflammation, which predisposes aortas to AAAs.
Methods
An expanded Materials and Methods section is available in the Online Data Supplement.
Human Aortic Samples
All protocols using human aortic samples were approved by the Ethical Committee of Chinese Academy of Medical Sciences and Peking Union Medical College. We obtained human AAA samples from 6 patients undergoing open surgical repair. AAA was diagnosed by ultrasound scanning before the operation. The control samples were trimmed from the adjacent nonaneurysmal aortic segments from the same patients. Information on the enrolled patients is provided in Online Table I .
Animal Experiments
All animal protocols were approved by the Animal Care and Use Committee at the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, and Peking Union Medical College. We used 2-to 3-month-old C57BL/6J male mice as young mice and 18-to 20-month-old C57BL/6J male mice as old mice. SIRT1-VSMC-specific transgenic (SV-Tg) Apoe −/− mice were generated by crossing SV-Tg mice 12 with Apoe −/− mice. We utilized a Cre/LoxP strategy to yield SIRT1-VSMC-specific knockout (SV-KO) mice. Age-matched male mice (young and old) and 4-to 6-month-old male mice (Apoe ) were infused with angiotensin II (Ang II) at a dosage of 1.44 mg/kg·per day or saline for 4 weeks as previously described. 21 In the CaCl 2 -induced AAA model, we induced AAA in both SV-KO (3 weeks) and SV-Tg (6 weeks) mice by periaortic application of 0.5 mol/L CaCl 2 as described previously.
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SIRT1 Deacetylase Activity Assay
SIRT1 activity was assayed using a SIRT1 deacetylase activity assay kit (Sigma) according to the manufacturer's instructions using microplate reader (Synergy 4; BioTek).
Senescence-Associated β-Galactosidase Activity Assay
Senescence-associated β-galactosidase (SA-β-gal) activity was quantitatively measured according to the rate of conversion of 4-methylumbelliferyl-β-d-galactopyranoside to the fluorescent hydrolysis product 4-methylumbelliferone at pH 6.0, as described previously. 23 The whole-aorta tissues were stained to determine SA-β-gal activity using a commercial kit (ab65351; Abcam) according to the manufacturer's instructions, as previously reported. 24 
Statistical Analyses
For all statistical tests, a P<0.05 was considered statistically significant, and all tests were 2 tailed. Normality tests were assessed via the Shapiro-Wilk statistics with SPSS software package (version 19.0). All statistical analyses were performed using GraphPad Prism (version 6.01) software.
Results
Reduction of SIRT1 Expression and Activity in Human AAA Formation
To establish the impact of AAAs on SIRT1, we first examined the expression of SIRT1 in human AAA samples. Human AAA tissues and their control adjacent aortic sections without aneurysm were obtained from patients undergoing open surgery (Online Table I ). As expected, proaneurysmal molecules, such as matrix metalloproteinase 2 (MMP2), human membrane type 1 MMP, and monocyte chemoattractant protein-1 (MCP-1/CCL2), were significantly elevated in human AAA sections (Figure 1A and 1B; Online Figure IA ) compared with adjacent nonaneurysmal aortic sections. The activity of SIRT1 in human AAA samples was also significantly lower than that in adjacent nonaneurysmal aortic sections ( Figure 1C ). These results suggest that SIRT1 reduction is involved in the development of human AAA formation. Because advanced age is a known risk factor for AAAs, we examined the effects of age on SIRT1 expression and activity in mouse aortas. SIRT1 activity was significantly lower in the whole aortas of aged mice than that of their young counterparts ( Figure 1D ). SIRT1 expression was decreased in whole aortas and substantially reduced in the abdominal aortas of aged mice compared with aortas from young mice ( Figure 1E ; Online Figure IB and IC). Moreover, the decrease in SIRT1 expression was mainly observed in the medial VSMCs of the suprarenal aortas ( Figure 1F and 1G), where AAAs most often develop in mice with Ang II infusion. 25 Therefore, the reduction of SIRT1 activity and expression in aged aortas may be linked to their susceptibility to AAAs.
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Aging Increases Ang II-Induced AAA Formation in Mice
Acute infusion of Ang II recapitulates many aspects of AAAs and is widely used to study AAAs. 25, 26 To clarify the effects of advanced age on AAA formation, 22 C57BL/6J male mice aged 18 to 20 months (aged) and 23 C57BL/6J male mice aged 2 to 3 months (young) were infused with the same dose of Ang II for 4 weeks. In saline-infused groups, 1 in 16 aged mice displayed expanded abdominal aorta to the extent of AAA, whereas none of the young mice displayed AAA formation (Figure 2A and 2B) . In Ang II-infused groups, the AAA A, Representative Western blots of SIRT1, membrane type 1-matrix metalloproteinase (MT1-MMP), monocyte chemoattractant protein-1 (MCP-1/CCL2), and MMP2 in human AAA samples and adjacent control aortas. B, Densitometric analysis of the protein levels of SIRT1, MT1-MMP, MCP-1/CCL2, and MMP2 in human AAA samples and adjacent control aortas (n=6). C, Quantitative analysis of SIRT1 activity in homogenates of human AAA samples and adjacent nonaneurysmal aortic sections (n=6). D, Fluorescence intensity indicating SIRT1 activity in homogenates of young mouse compared with that of the aged mouse (n=6). E, Representative Western blots of SIRT1 and p21 in abdominal aortas (AA) from aged and young mice. Adventitial tissue was removed from the aorta as much as possible, and each sample was pooled from 3 abdominal aortas together for immunoblot analysis. F, Representative immunofluorescent staining of SIRT1, α-smooth muscle actin (SMA), and 4′,6-diamidino-2-phenylindole (DAPI) in suprarenal aortas of young and aged mice (scale bars, 50 µm). G, Densitometric analysis of the protein level of SIRT1, which is normalized to α-SMA, in suprarenal aortas of young and aged mice (n=9). Three different visual fields were captured in each slide.
by guest on November 22, 2016 http://circres.ahajournals.org/ Downloaded from incidence in aged mice was 86.4% (19/22) , much higher than the 13.0% (3/23) observed in young mice (Figure 2A and 2B ). Approximately 22.7% (5/22) of Ang II-infused aged mice died from aortic rupture, whereas only 4.3% (1/23) of Ang IIinfused young mice died ( Figure 2C ). Additionally, Ang II infusion caused a greater increase in maximal abdominal aortic diameter, the ratio of total aortic weight to body weight in aged mice than in young mice ( Figure 2D and 2E), accompanied with increased expression levels of MCP-1/CCL2, a critical chemokine in inflammatory cell recruitment for vascular inflammation and AAAs, 27, 28 and MMP-2 as well ( Figure 2F and 2G). Accordingly, inflammatory cell infiltration as determined by CD45 immunostaining was increased in the aortas of Ang II-infused aged mice compared with those of Ang II-infused young mice ( Figure 2H and 2I). These results indicate that aging remarkably increases Ang II-induced AAA formation in mice.
VSMC-Specific Ablation of SIRT1 Exacerbates Ang II-Induced AAA Formation and Related Pathological Changes In Vivo
To establish a causative link between the reduction of SIRT1 and AAA formation, we crossbred a conditional allele of Sirt1 (Sirt1 flox ) mice with mice with Cre recombinase driven by the . B and C, The incidence (B) and survival curve (C) of AAA in Ang II-infused young mice (n=23) compared with that in aged mice (n=22). There was no AAA formation in saline-infused young mice (n=16), and 1 of 16 saline-infused aged mice developed AAA. D and E, Maximal abdominal aortic diameter (D) and the ratio of aorta weight to body weight (E) in saline-and Ang II-infused young and aged mice. F and G, mRNA levels of monocyte chemoattractant protein-1 (MCP-1/CCL2; F) and matrix metalloproteinase 2 (MMP-2; G) detected by real-time polymerase chain reaction in aorta homogenates from young and aged mice infused with saline or Ang II for 4 wk. H, Representative immunostaining with CD45 in the suprarenal aortic wall of young and aged mice infused with saline or Ang II forSM22α promoter to obtain SV-KO (SM22-Cre +/− ; Sirt1 flox/flox ) mice (Online Figure IIA-IID) , and their Sirt1 flox/flox littermates were used as WT controls. Although SIRT1 activity and expression in the aortas of SV-KO mice were markedly reduced compared with their littermates (Online Figure  IIE and IIF) , there was no difference in the gross morphology of aortas between saline-infused SV-KO and WT mice ( Figure 3A) . However, 4 weeks of Ang II infusion caused a 64.2% (34/53) incidence of AAA in SV-KO mice compared with 19.6% (9/46) in WT mice ( Figure 3B ). Approximately 34.0% (18/53) of Ang II-infused SV-KO mice died because of aortic rupture, whereas only 8.7% (4/46) of Ang II-infused WT mice died ( Figure 3C ; Online Table II) . To exclude the effect of SM22 deficiency after Cre knockin, we treated 10 SM22-Cre +/− ; Sirt1 +/+ mice with Ang II for 4 weeks and found that only 2 developed AAAs, suggesting that SM22 deficiency in 1 allele does not influence Ang II-induced AAA formation. In addition, compared with Ang II-treated WT mice, the maximal abdominal aortic diameter, the ratio of total aortic weight to body weight, and the elastin degradation score were remarkably higher, whereas the elastic fiber content was significantly lower in Ang II-treated SV-KO mice (Figure 3D -3F; Online Figure IIIA and IIIB). The systolic blood pressure, heart rate, and serum lipid levels after Ang II infusion did not differ between SV-KO mice and WT mice (Online Tables III and IV) . Aberrant levels of oxidative stress play critical roles in AAA initiation and progression. 21 Therefore, we analyzed medial oxidative stress by immunostaining for 3-nitrotyrosine and 8-hydroxydeoxyguanosine (8-OH-dG), 2 oxidative stress . B and C, The incidence (B) and survival curve (C) of Ang II-induced AAA in SIRT1-VSMC-specific knockout (SV-KO) mice (n=53) compared with that in wild-type (WT) mice (n=46). There was no AAA formation in saline-infused mice (n=12), and the number of mice that developed AAA included the deaths caused by abdominal aortic rupture. D, The maximal abdominal aortic diameter in saline-and Ang II-infused mice. E, Representative staining with elastin and elastin degradation score in suprarenal aortas from saline-and Ang II-infused mice. The magnified photographs were taken at the location where the most severe elastin degradation occurred (scale bars, 150 and 50 µm; magnified photographs). F, Aorta homogenates were obtained from WT and SV-KO mice infused with saline or Ang II for 4 wk. Western blot and densitometric analysis of the protein levels of monocyte chemoattractant protein-1 (MCP-1/CCL2) and matrix metalloproteinase 2 (MMP2) in aorta homogenates (n=4-6).
by guest on November 22, 2016 http://circres.ahajournals.org/ Downloaded from biomarkers. Aortas from Ang II-infused SV-KO mice exhibited a significant increase in the levels of both 3-nitrotyrosine and 8-OH-dG compared with those of Ang II-infused WT mice (Online Figure IIIC and IIID) . In saline-infused mice, few inflammatory cells were found in the suprarenal aortic wall (Online Figure IVA) . After Ang II infusion, inflammatory cell infiltration was increased in the aortas of Ang II-infused SV-KO mice compared with those of Ang II-infused WT mice (Online Figure IVA) and was accompanied by a significantly higher expression of MCP-1/CCL2 ( Figure 3F ; Online Figure  IVB ). SV-KO mice also displayed increased MMP2 protein expression and activity after Ang II infusion ( Figure 3F ; Online Figure IVC) , with an upregulation of membrane type 1-MMP (Online Figure IVD) and increased TIMP1 repression (Online Figure IVD) . These results indicate that the VSMCspecific ablation of SIRT1 exacerbates AAA formation and related pathological changes. Table II) . Compared with Ang II-treated Apoe −/− mice, the maximal abdominal aortic diameter, the ratio of total aortic weight to body weight, and the elastin degradation score were remarkably lower, whereas the elastic fiber content was significantly higher in Ang II-treated SV-Tg Apoe Tables III and IV) . Moreover, the VSMC-specific SIRT1 transgene remarkably attenuated the increased levels of oxidative stress (Online Figure VC and VD 
VSMC-Specific
SIRT1 in VSMCs Inhibits Calcium ChlorideInduced AAA Formation
To further investigate whether the inhibitory effects of SIRT1 in VSMCs on AAA formation are independent of Ang II, another type of mouse AAA model, calcium chloride (CaCl 2 )-induced AAA 22 was applied in both SV-KO and SV-Tg mice. We found that 3 weeks after CaCl 2 treatment, the ratio of total aortic weight to body weight and the maximal external and internal abdominal aortic diameter were significantly increased in SV-KO mice compared with those of their littermates ( Figure 5A through 5D) , and a substantial increase in the elastin degradation score was also observed ( Figure 5E and 5F). Moreover, in situ immunochemical staining showed that compared with WT mice, SV-KO mice displayed significantly increased MCP-1/CCL2 and MMP-2 protein expression after CaCl 2 treatment (Online Figure VIIA through VIID). To determine the protective role of SIRT1 transgene 
SIRT1 Is Crucial for Suppression of Vascular Cell Senescence and p21 Expression in AAAs
Ang II infusion accelerates vascular cell senescence in vivo, which can be characterized by SA-β-gal staining, as reported in the previous study, 30 and we found that SA-β-gal-positive staining was mainly located in the media of the aortas (Online Figure IXA) , suggesting a role of medial VSMC senescence in Ang II-induced AAAs. To investigate the role of SIRT1 in vascular cell senescence, SA-β-gal staining was performed in the aortas of Ang II-or saline-infused SV-KO mice and SV-Tg Apoe −/− mice and their respective controls. In salineinfused groups, few obvious SA-β-gal-positive areas were detected in both SV-KO mice and SV-Tg Apoe −/− mice. Ang II infusion led to the enlargement of SA-β-gal-positive regions in the aortas of WT mice, whereas the SIRT1-specific loss of function in VSMCs further increased the areas of SA-β-gal-positive staining ( Figure 6A ). The increase of SA-β-gal-positive staining in the aortas of SV-KO mice mainly occurred at medial VSMCs ( Figure 6B ). Moreover, Ang IIinduced vascular cell senescence was further supported by the results of assays for SA-β-gal activity in the homogenates of whole aortas (Online Figure IXB) . In contrast, SA-β-gal staining was suppressed in SV-Tg Apoe −/− mice ( Figure 6C ). Notably, SA-β-gal-positive staining in medial VSMCs was Figure 6D ). As expected, the SA-β-gal activity assay also confirmed the antiaging effect of SIRT1 overexpression (Online Figure IXC) . Furthermore, vascular aging was demonstrated by increased pulse wave velocity in the left common carotid artery in vivo. 31, 32 As expected, Ang II caused a modest increase in pulse wave velocity in WT mice, whereas it robustly increased the value in SV-KO mice (Online Figure IXD) , and this trend was reversed in SV-Tg Apoe −/− mice (Online Figure  IXE) . These results indicate that the manipulation of SIRT1 expression or activity affects Ang II-induced vascular cell senescence in AAAs.
To further investigate the role of vascular cell senescence in aging-increased AAA formation, we examined SA-β-galpositive areas in the aortas of young and aged mice with or without Ang II infusion. As shown in Figure 6E , the levels of SA-β-gal-positive areas in the aortas of saline-infused young and aged mice were low, and there was no difference between aged and young aortas; similar results were observed for SA-β-gal activity (Online Figure IXF) , suggesting that vascular cell senescence was low and unaltered in aortas with advanced age. However, Ang II infusion significantly increased SA-β-gal-positive areas and SA-β-gal activity in the aortas of aged mice compared with those of young mice ( Figure 6E ; Online Figure IXF ). The increase of SA-β-gal staining and SA-β-gal activity caused by Ang II was significantly greater in aged mice than that in young mice, indicating that aged aortas were more sensitive to Ang II-induced vascular senescence ( Figure 6E ; Online Figure  IXF) . Correspondingly, the increase of SA-β-gal-positive staining in the suprarenal aortas of aged mice mainly occurred at medial VSMCs ( Figure 6F ). Cellular senescence marker p21 can be suppressed by SIRT1 in a p53-dependent and p53-independent manner. 33, 34 We found that acetylated p53 (Ac-p53) and p21 expression levels were higher in the whole aorta homogenates from Ang II-infused SV-KO mice ( Figure 7A ), and total p53 was also significantly increased ( Figure 7A ), whereas the SIRT1 transgene significantly reversed the increased protein levels of Ac-p53, total p53 and p21 in Ang II-infused Apoe −/− mice ( Figure 7B ). These results suggest that SIRT1 inhibited Ang II-induced p21 expression by deacetylation of p53 in AAAs. The increased p21 expression caused by Ang II was significantly greater in the aortas of aged mice than that in young mice ( Figure 7C ). Similarly, increased p21 expression was found in human AAA samples ( Figure 7D ). These results provide evidence that the increased vascular senescence and deregulated p21 expression caused by the reduction of SIRT1 participates in the promotional effect of aging on AAAs.
Suppression of p21 in VSMCs Abolishes Enhanced Nuclear Factor-κB Activation and MCP-1/CCL2 Expression by SIRT1 Inhibition
To further explore how SIRT1 reduction in VSMCs promotes Ang II-induced AAAs, gene expression microarray analysis was performed using RNA isolated from the aortas of Ang II-treated SV-KO mice and their Sirt1 flox/flox littermates. Interestingly, analysis using ingenuity pathway analysis software revealed that the inflammatory response pathway was the pathway most affected by SIRT1 deficiency (Online Figure  XA and XB and Online Table V), which was consistent with the aforementioned result of Online Figure IVA . Accordingly, nuclear factor (NF)-κB signaling was significantly activated Thus, we suspected that the promotional effect of SIRT1 reduction on Ang II-induced MCP-1/CCL2 expression might rely on the existence of p21 and VSMC cell senescence. To verify this hypothesis, adenovirus-mediated p21 RNA interference (RNAi) was introduced in VSMCs isolated from the aortas of SV-KO mice or control WT mice before treated with saline or Ang II. As expected, p21 mRNA level in both saline-and Ang II-treated VSMCs was significantly repressed by transfection of Ad-p21 RNAi (vectors for adenovirus-mediated knockdown of p21; Online Figure XVI) . The results of SA-β-gal staining indicated that p21 knockdown not only blocked Ang II-induced VSMC senescence but also eradicated the promotional effect of SIRT1 knockout (Figure 8A and 8B; Online Table VII) . Accordingly, Ang II-increased expression of MCP-1/CCL2 in SV-KO VSMCs was also significantly reduced by p21 knockdown ( Figure 8C ). Finally, we also performed ChIP assay to detect the binding level of NF-κB on MCP-1/CCL2 promoter in saline-or Ang II-treated human VSMCs infected by either Ad-SIRT1 RNAi or Ad-p21 RNAi or both of them. Three binding sites of NF-κB on human MCP-1/CCL2 promoter by ChIP assays were selected out from the 5 potential binding sites to assess the impact of p21 knockdown to the effect of SIRT1 RNAi on transcriptional activation of MCP-1/CCL2 (Online Figure XVII) . The results indicated that p21 knockdown by RNAi almost completely blocked the promotional effect of SIRT1 knockdown on Ang II-increased RelA/p65 binding on the 3 potential NF-κB binding sites of MCP-1/ CCL2 promoter ( Figure 8D through 8F) . These results support that p21-mediated VSMC cell senescence by SIRT1 reduction facilitates the transcriptional activation of MCP-1/ CCL2, which may promote inflammatory cell recruitment and vascular inflammation in AAAs.
Discussion
In the present study, we demonstrated that SIRT1 acts as a novel molecular link that retards vascular senescence and inflammation to prevent AAA initiation and development. There are several major findings in this study. First, the expression and activity of SIRT1 were significantly decreased in human AAA samples. Second, SIRT1 in VSMCs was substantially downregulated in the suprarenal aortas of aged mice, in which AAAs induced by Ang II infusion were significantly elevated. Third, SIRT1 reduction in VSMCs amplified Ang II-induced vascular aging and AAA formation in mice in vivo, whereas genetic activation of SIRT1 in VSMCs displayed the opposite effect. The inhibitory effect of SIRT1 on AAA formation was also confirmed in the CaCl 2 -induced AAA model. Fourth, the reduction of SIRT1 was shown to increase vascular cell senescence and upregulate p21 expression and enhance vascular inflammation. Moreover, suppression of p21-dependent vascular cell senescence by SIRT1 inhibited Ang II-induced inflammation.
AAA incidence increases steeply by 40% every 5 years in men aged >65 years, indicating that age is a major risk factor for AAAs. 2 Why advanced age (>65 years) precipitates AAA development and progression is unknown. In the present study, we found that SIRT1 protein and activity were significantly suppressed in the aortic VSMCs of aged mice, and vascular cell senescence in the aortas of aged mice was low and comparable to that of young mice under natural conditions. Concomitantly, only a few incidences of spontaneous AAAs were observed in the same conditions. In contrast, AAA formation and vascular cell senescence in SV-KO mice and aged mice were significantly increased by Ang II infusion, indicating that the SIRT1 reduction in advanced age creates an environment that facilitates AAA initiation and progression caused by Ang II, but does not directly instigate AAAs. This conclusion is supported by human epidemiological evidence indicating that aging is a risk factor for AAA and only a small number of men with advanced age develop AAAs. Accumulating evidence has shown that SIRT1 plays an important role in healthy aging and age-related diseases, 8, 9 which suggests that the SIRT1 reduction in advanced age may also predispose individuals to the aging of other tissues and to agerelated cardiovascular diseases.
Systemic inflammation has been linked to multiple chronic diseases of aging and may even contribute to their causation. [35] [36] [37] Although increases in chronic inflammation have been detected in the vasculature with age, 5-7 the molecular mechanisms that link vascular aging and inflammation to AAA formation remain elusive. Previous studies have identified important roles for p53 in promoting aging and NF-κB in mediating inflammatory response, both of which can be targeted by SIRT1. 34, [38] [39] [40] [41] In the present study, we found that SIRT1 reduction increased Ang II-induced VSMC senescence and upregulated p53 acetylation and p21 protein.
Inflammatory NF-κB activation and MCP-1/CCL2 were significantly increased in parallel with increased vascular cell senescence. Accordingly, AAA formation was significantly enhanced by SIRT1 reduction in both SV-KO mice and in aged mice (Online Figure XVIIIA) . Moreover, Ang II-activated NF-κB transcription of MCP-1/CCL2 expression was significantly decreased by suppression of p21 in SIRT1 knockout VSMCs. These results suggest that the deregulated SIRT1-p53-p21 axis in VSMCs in response to Ang II accelerates NF-κB-induced vascular inflammation and renders aortas susceptible to AAAs. To the best of our knowledge, this is the first time that a direct link between vascular cell senescence and vascular inflammation to AAA formation by SIRT1 reduction has been reported. Importantly, AAA formation and the related pathological and molecular changes could be effectively inhibited by VSMC-specific overexpression of SIRT1, which provides a potential therapeutic target for AAAs (Online Figure XVIIIB) . However, whether SIRT1 reduction in VSMCs induces NF-κB-mediated vascular inflammation and accelerates AAA formation by downregulation of p53/p21 in vivo requires further investigation. In addition, our results highlight the importance of VSMC senescence in the development of vascular inflammation and AAAs, which is also consistent with the well-known roles of VSMCs in AAA formation. 21, 29, 42, 43 In summary, our findings indicate that the age-related reduction of SIRT1 in VSMCs predisposes aortas to AAAs by facilitating p21-dependent vascular cell senescence, secretion of inflammatory cell recruitment molecules, and vascular inflammation. These findings indicate a direct link between vascular cell senescence and AAAs through vascular inflammation that provides a deeper understanding of the relationship between aging and age-related vascular diseases. What Is Known?
• In humans, the incidence of abdominal aortic aneurysm (AAA) increases dramatically with age.
• SIRT1 is highly expressed in the vasculature and plays a protective role in vascular remodeling, aortic stiffness and dissection, and atherosclerosis in mice.
What New Information Does This Article Contribute?
• The expression and activity of SIRT1 are significantly decreased in human AAA samples.
• SIRT1 in VSMCs is downregulated in the suprarenal aortas of aged mice, in which AAAs induced by Ang II infusion were significantly elevated.
• VSMC-specific knockout of SIRT1 accelerates Ang II-or CaCl 2 -induced AAA formation, whereas VSMC-specific overexpression of SIRT1 displays the opposite effect.
• SIRT1 reduction increases Ang II-induced vascular cell senescence, upregulates the expression of p21 and enhances inflammatory cell recruitment for vascular inflammation in AAAs.
Age is a major risk factor for AAAs. Uncontrolled growth of AAAs is a life-threatening vascular disease without an effective pharmaceutical treatment. Our study shows that age-associated SIRT1 reduction in VSMCs accelerates the formation and rupture of AAAs, whereas VSMC-specific overexpression of SIRT1 suppresses AAA formation and progression. SIRT1-mediated inhibition of vascular cell senescence suppresses vascular inflammation in AAAs. These findings suggest that the manipulation of SIRT1 activation may effectively inhibit vascular cell senescence, vascular inflammation, and delay or prevent AAA initiation and progression.
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Online methods
Animal experiments
All animal protocols were approved by the Animal Care and Use Committee at the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College.
We used 2-to 3-month-old C57BL/6J male mice as young mice and 18-to 20-month-old C57BL/6J male mice as aged mice. We established SV-Tg mice as previously described 
Analyses and quantification of Ang II-induced AAAs
We used 4-to 6-month-old male mice on a normal chow diet. All age-matched mice (Apoe or saline for 4 weeks using Alzet osmotic pumps (model 3 / 31 2004; DURECT Corp.). The detailed manipulation was performed as previously described 3 . In the last week of the experiment, the mice underwent all physiologic assessments and then were sacrificed. The direct method was used to measure the outer diameter of the suprarenal aorta. After the aorta was dissected free from the surrounding connective tissue, a ruler was set aside and a picture was taken with a digital camera. The image of the aorta was used to measure the outer diameter of the suprarenal aorta by a researcher blind to group assignment. Suprarenal regions of abdominal aorta were identified between the last pair of intercostal arteries and the right renal branch. The adventitial circumferences at the maximal expanded portion of the suprarenal aorta were quantified as the maximal abdominal aortic diameter. The maximum width of the abdominal aorta was analyzed using Image Pro Plus software (Media Cybernetics) after adjusting the scale according to the ruler in aorta pictures. At least 3 measurements of the maximal expanded portion of the suprarenal aorta for each mouse were averaged before calculating the mean of each experimental group. Aneurysm formation was defined as the increase in the external width of the suprarenal aorta by 50% or greater compared with that in salineinfused mice as previously described. 
Analyses and quantification of CaCl2-induced AAAs
We also induced AAA in mice (WT, SV-Tg or SV-KO) by periaortic application of 0.5 mol/l CaCl2 as previously described with little modification 4 . Briefly, mice aged 8-12 weeks were anesthetized and underwent laparotomy. The abdominal aorta between the renal arteries and bifurcation of the iliac arteries was dissociated from the surrounding retroperitoneal structures under a stereo microscope (Nikon). Then, 0.5 mol/l CaCl2-treated cotton gauze was applied to the external surface of the aorta. NaCl (0.9%) was used in the sham control mice instead of CaCl2. After 15 minutes the incision was closed after aorta was rinsed with saline and the mice were allowed to recover. Three (SV-KO) or six (SV-Tg) weeks later, the mice were sacrificed and underwent laparotomy. Infrarenal regions of abdominal aorta were identified between the right renal branch and bifurcation of the iliac arteries. The methods used for quantification of CaCl2-induced AAAs are described in Methods section of Ang IIinduced AAAs on infrarenal regions instead of suprarenal regions. The aortic internal diameter of mice was assessed in a blinded manner using a VisualSonics Vevo770 ultrasound biomicroscope (VisualSonics Inc, Toronto, ON, Canada) with a 30-MHz linear array ultrasound transducer and the inner lumen diameter at the maximal expanded portion of the infrarenal aorta were quantified as the internal maximal diameter.
Blood pressure and serum lipid measurements
The heart rate and systolic blood pressure of the animals were measured using tail-cuff plethysmography (BP-2000 System; Visitech Systems, Apex, NC) as described previously 1 . Blood samples were obtained from the mice before sacrifice. Serum cholesterol, triglyceride, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) levels were measured at the clinical laboratory of Peking Union Medical College Hospital.
Transit-time (TT) method for performing pulse-wave velocity (PWV) measurements
The TT method estimates the PWV from the pressure wave transit time between two measurement locations separated by a known distance as previously described 5 . Pulse-wave Doppler ultrasound velocity measurements were consecutively performed at the distal and proximal locations while CIRCRES/2016/308895/R2 4 / 31 simultaneously recording the electrocardiogram (ECG) signal over a short period, during which the mouse was observed to have stable heart and breathing rates. TT was determined by subtracting the distal arrival time between the ECG R-wave peak and the foot of the velocity upstroke from the similarly determined proximal arrival time. As a threshold for consistent detection of the upstroke, arrival times were calculated relative to the time at which 20% of the peak value was attained. The left common carotid artery (LCCA) was chosen as a measurement target because it was easily accessible and offered a uniform and branch-free pathway of over approximately 10 mm between the aortic arch and the bifurcation. The distance between measurement sites was determined from a B-mode image encompassing both the distal and proximal locations. Proximal velocity measurements were taken 1 mm downstream from the aortic arch. Distal velocity measurements were taken 1.5 mm upstream from the bifurcation.
TT measurements were performed using a VisualSonics Vevo770 ultrasound biomicroscope (VisualSonics Inc., Toronto, ON, Canada). The mechanically scanned, single-element transducer had a 6-mm focal length and an f-number of 2. B-mode data were acquired at 40 MHz with a 30 frame-persecond (fps) frame rate. Doppler data were acquired at 30 MHz with a 50 kHz pulse-repetition frequency (PRF). The ECG signal was detected using a heart rate monitoring system (VisualSonics Inc., Toronto, ON, Canada) smoothed with a 1-kHz low-pass filter and digitized by the Vevo770 system at 8 kHz. The results were processed using VisualSonics analysis software.
SIRT1 deacetylase activity assay
SIRT1 activity was assayed using a SIRT1 deacetylase activity assay kit (Sigma) according to the manufacturer's instructions. Briefly, SIRT1 was immunoprecipitated using a SIRT1 antibody (Millipore) from whole-aorta homogenates (200 μg of protein) in immunoprecipitation (IP) buffer. The SIRT1 substrate reagent and NAD + were added to the SIRT1-conjugated beads (sc-2002; Santa Cruz Biotechnology) and incubated at 37 °C for 80 minutes after final washing. The substrate-SIRT1 mixture was placed on a 96-well plate, and the developer reagent was added to the wells at 37 °C for 20 minutes. The plate was read using a spectrophotometer with an excitation wavelength of 360 nm and an emission wavelength of 445 nm (Synergy 4 microplate reader; BioTek).
SA-β-gal activity assay
SA-β-gal activity was quantitatively measured according to the rate of conversion of 4-methylumbelliferyl-β-d-galactopyranoside (MUG) to the fluorescent hydrolysis product 4-methylumbelliferone (4-MU) at pH 6.0, as described previously 6 . Briefly, aorta tissues were homogenized in the lysis buffer (5 mM CHAPS, 40 mM citric acid, 40 mM sodium phosphate, 0.5 mM benzamidine, and 0.25 mM PMSF, pH 6.0) and kept on ice for 1 h. The lysates were centrifuged at 12,000 × g for 5 mins, and the supernatant was mixed with 2× reaction buffer (40 mM citric acid, 40 mM sodium phosphate, 300 mM NaCl, 10 mM β-mercaptoethanol, and 4 mM MgCl2 [pH 6.0] with 1.7 mM MUG), which was placed into a 37 °C water bath for 3 h. We added 50 μL reaction mix to 500 μL 400 mM sodium carbonate stop solution (pH 11.0), which was read at 150 μL/well in a 96-well plate using a Synergy 4 plate reader (BioTek) with excitation at 360 nm and emission at 465 nm. Normalized SA-β-gal activity was expressed as the observed fluorescence divided by the mg of total protein in the assay.
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The whole-aorta tissues were stained to determine SA-β-gal activity using a commercial kit (ab65351; Abcam) according to the manufacturer's instructions, as previously reported 7 . Briefly, the aortas were fixed in 2% formaldehyde containing 0.2% glutaraldehyde for 15 minutes and washed with PBS twice; subsequently, samples were incubated at 37 °C for 24 h in the staining solution (1 mg/ml X-gal in dimethylformamide, 5 nM potassium ferrocyanide, 5 nM potassium ferricyanide, 40 mM citric acid/sodium phosphate, 0.15 M NaCl, and 2 mM MgCl2, pH 5.9). The cells with blue color were considered SA-β-gal positive. In primary vascular smooth muscle cells (VSMCs), SA-b-gal activity was also determined as previously described. 8 VSMCs were counterstained with 2.5 µg mL -1 DAPI, and the proportion of SA-b-gal activity-positive cells was quantified using light and fluorescence microscopy.
Histological analyses
After hemodynamic measurements, the animals were sacrificed. After the mice were sacrificed, aortas from the ascending aorta to the bifurcation of the common iliac artery were isolated. After macroscopic analysis, suprarenal abdominal aortas were subjected to histology analysis. For morphological analysis, the aortas were perfused with normal saline and fixed with 4% paraformaldehyde-PBS at physiological pressure for 5 minutes. Whole aortas were harvested, fixed for 24 h, and embedded in paraffin. For characterization of cross sections, aortic sections were collected serially from the proximal to the distal aorta. Histology was determined in sections (5 μm each) that were taken from suprarenal regions of abdominal aorta at intervals of 500 μm. At least 10 sections were analyzed per mouse. Paraffin sections were stained with elastin van Gieson staining or used for immunostaining. For the semi-quantification of elastin degradation, we used a standard for the elastin degradation score as previously described 3 . The grades were as follows: score 1, no degradation; score 2, mild elastin degradation; score 3, severe elastin degradation; score 4, aortic rupture. Elastic fiber content was quantified as described previously. 9 Briefly, after the cross sections were stained with elastin van Gieson staining, elastic fiber content was quantified in five separate representative images of each section by a single blinded observer using Image Pro Plus software (Media Cybernetics) after adjusting the scale. The areas of aortic media and the elastic fibers were calculated after they were individually outlined. The respective areas were averaged from all the images of a given aortic section and the ratio of elastic fiber content to total aortic media was determined.
Immunohistochemistry
Slides were deparaffinized, and endogenous peroxidase activity was quenched with 3% (vol./vol.) hydrogen peroxide in 10% PBS for 10 mins. Nonspecific binding sites were blocked with 10% bovine serum in PBS at room temperature for 1 h. The slides were incubated at 4 °C overnight with diluted primary antibodies and with biotinylated secondary antibody at 37 °C for 30 mins and subsequently with horseradish peroxidase-labeled streptavidin solution at 37 °C for 20 mins. The slides were then stained with diaminobenzidine and counterstained with hematoxylin. The primary antibodies used were human SIRT1 (1104-1, 1:250 dilution; EPITOMICS), α-smooth muscle actin (A5691, 1:400 dilution; Sigma-Aldrich), p21 (ab2961, 1:80 dilution; Abcam), MCP-1 (sc-1784, 1:400 dilution; Santa Cruz), leukocyte common antigen, CD45 (clone Ly-5, 1:100 dilution; BD Pharmingen), 8-OH-dG (MOG-020P, 1:100 dilution; Japan Institute for the Control of Aging), and nitrotyrosine (06-284, 1:500 dilution; 6 / 31 Millipore). The medial 8-OH-dG or nitrotyrosine content in the suprarenal aortic wall of mice was analyzed by calculating the integration optical density value of positive staining within the media using Image-Pro Plus software (Media Cybernetics). A mean value was determined from at least four sections in each animal.
Immunofluorescent staining
Suprarenal abdominal aortas from young and aged mice were subjected to immunofluorescent analysis. The aortas were fixed with 4% paraformaldehyde-PBS for 24 hours, embedded in paraffin, and serial sections (5 μm each) at 500 μm intervals were made using suprarenal abdominal aortas as previously described. 3 After slides were deparaffinized, nonspecific binding sites were blocked in 10% bovine serum in PBS at room temperature for 1 h. The slides were then incubated at 4 °C overnight with diluted primary antibodies and with fluorescent-coupled secondary antibodies at 37 °C for 45 mins in the dark followed by DAPI for 5 mins at room temperature in the dark. The slides were then rinsed with PBS and evaluated under a fluorescence microscope. The primary antibodies used were human SIRT1 (LS-B4520, 1:100 dilution; LifeSpan Biosciences), mouse SIRT1 (07-131, 1:100 dilution; Millipore), and α-smooth muscle actin (A5691, 1:100 dilution; Sigma-Aldrich).
Cell culture, adenovirus generation and infection
Primary VSMCs were isolated from 2-to 3-month-old male mice and maintained in Dulbecco's modified Eagle's medium (DMEM) containing 15% FBS at 37 °C in a humidified atmosphere of 5% CO2 and 95% air as previously described 9 . Passages 3 to 6 of VSMCs at 70-80% confluence were used for experiments. Human aortic smooth muscle cells (HASMCs) were purchased from ScienCell (Cat No: 6110, ScienCell) and cultured in Smooth Muscle Cell Medium (SMCM, Cat No: 1101, ScienCell) supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin, smooth muscle cell growth supplement (SMCGS, Cat. No. 1152, ScienCell), and 10% FBS. The adenovirus-mediated knockdown of SIRT1 (Ad-SIRT1 RNAi), p21 (Ad-p21 RNAi) and control vector (Ad-U6) were generated using the AdEasy vector kit (Quantum Biotechnologies) as described in the supplier's protocol. The RNAi sequences were reported previously 10, 11 . The VSMCs were infected for 24 hours with the above adenovirus at an MOI of 100, washed and incubated in 10% FBS-medium without virus and treated with saline, 100 nM angiotensin II (Sigma) or 10 mM CaCl2 (Sigma) for 24 hours.
Real-time PCR
Total RNA was extracted using TRIzol reagent (Invitrogen) according to the manufacturer's protocol. Two micrograms of total RNA was used for the first-strand synthesis with cDNA M-MuLV Reverse Transcriptase (New England Biolabs) using random primers. The QuantiTect SYBR Green RT-PCR Kit (QIAGEN) was used for the amplification reactions using the 1-step protocol described by the manufacturer with the Applied Biosystems Real-time PCR Detection System. The fluorescence curves were analyzed using StepOne Software (Version 2.1). The primers are listed in Online Table Ⅷ . 7 / 31 Western blots were performed as described previously 12 . The primary antibodies used were human SIRT1 (1104-1, 1:1000 dilution; EPITOMICS), human MCP-1 (ab9669, 1:1000 dilution; Abcam), human and mouse MMP2 (sc-13595, 1:1000 dilution; Santa Cruz), human and mouse GAPDH (5174, 1:3000 dilution; Cell Signaling Technology), β-actin (4970, 1:3000 dilution; Cell Signaling Technology), mouse SIRT1 (07-131, 1:1000 dilution; Millipore), mouse p53 (Sc-73566, 1:1000 dilution; Santa Cruz), mouse Ac-p53 (06-758, 1:500 dilution; Millipore), mouse p21 (05-345, 1:1000 dilution; Millipore), mouse MCP-1 (ab7202, 1:2000 dilution; Abcam), mouse MT1-MMP (ab51074, 1:2000 dilution; Abcam), mouse TIMP2 (ab1828, 1:2000 dilution; Abcam), mouse TIMP1 (sc-5538, 1:1500 dilution; Santa Cruz), mouse p65 (8242, 1:1000 dilution; Cell Signaling Technology), mouse Phospho-NF-κB p65 (Ser536) (3033, 1:1000 dilution; Cell Signaling Technology). Western blots were quantified densitometrically using Quantity One software (Bio-Rad), and the intensity values were normalized to GAPDH or β-actin.
Western blot analyses
Matrix metalloproteinase (MMP) activity
The detection of MMP activity was performed as previously reported 13 . Five micrograms of protein in aorta homogenates was electrophoresed in SDS-PAGE gels containing gelatin. The gels were washed with 2.5% Triton X-100 for 30 mins and incubated for 12-40 h in zymography development buffer at 37 °C. The gel was subsequently stained with Coomassie brilliant blue.
Chromatin immunoprecipitation
ChIP assays were carried out as previously described.
14 Briefly, cells or tiny tissue pieces were crosslinked with 1% formaldehyde at room temperature for 10 min. The reaction was quenched with 125 mM glycine. Cells were collected, washed twice with cold PBS and resuspended in cell collection buffer (100 mM Tris-HCl, pH 9.4, with 10 mM DTT and complete protease inhibitor cocktail (Sigma) at room temperature for 30 min and 30 °C for 15 min. Nucleus/Chromatin preparation buffers I and II (buffer I: 10 mM EDTA, 0.5 mM EGTA, 10 mM Hepes, pH 6.5, with 0.25% Triton X-100; buffer II:1 mM EDTA, 0.5 mM EGTA, 10 mM Hepes, pH 6.5, 200 mM NaCl; Both are freshly added with complete protease inhibitor cocktail (Sigma)) were used to isolate nuclei. human MCP-1 promoters using AliBaba2.1 (www.generegulation.com/pub/programs/alibaba2) to find the potential binding sites of interested transcription factors. Primer sequences were listed in Online Table Ⅸ .
Statistical analyses
For all statistical tests, a P value of <0.05 was considered statistically significant, and all tests were 2-tailed. Fisher's exact test was applied to the comparisons of AAA incidence and log-rank (Mantel-Cox) test was used for survival comparison between groups. Normality tests were assessed via the ShapiroWilk statistics with SPSS software package (version 19.0). Normally distributed datasets were analyzed with the unpaired Student's t test for 2 independent groups or paired t test for 2 dependent groups, and the one-way analysis of variance (ANOVA) followed by the post Bonferroni's multiple comparisons test for ≥3 groups. Quantitative results are expressed as the mean ± standard deviation (SD) for normally distributed datasets. Where a normal distribution could not be confirmed, nonparametric tests were used (Mann-Whitney U test for 2 independent group, Wilcoxon signed rank test for 2 paired groups and the Kruskal-Wallis test with post Dunn's multiple comparisons test for ≥3 groups) and quantitative results are expressed as the median with interquartile range. All statistical analyses were performed using GraphPad Prism (version 6.01) software and the detailed statistical methods were listed in Online Table Ⅹ . 
